Sintilimab and Lenalidomide as a Treatment for CAEBV
Clinical trial NCT04518982 · UNKNOWN
Trial details
- NCT number
- NCT04518982
- Sponsor
- Zhao Wang
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2021-08-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.